Nutriband (NTRB) Stock Price
Nutriband Price
Revenue has compounded at 35.3% per year over the past 7 years to 2.04 M USD. Nutriband's net margin stands at -404.1%, up from -592.2% several years earlier. Analysts set a median price target of 15.30 USD, implying 387.3% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 12% above its 52-week low.
Nutriband stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Nutriband over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Nutriband stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Nutriband's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Nutriband Price |
|---|---|
| 8/10/2026 | 3.14 USD |
| 8/7/2026 | 3.11 USD |
| 8/6/2026 | 2.91 USD |
| 8/5/2026 | 2.83 USD |
| 8/4/2026 | 2.81 USD |
| 8/3/2026 | 2.81 USD |
| 7/31/2026 | 2.85 USD |
| 7/30/2026 | 2.91 USD |
| 7/29/2026 | 2.99 USD |
| 7/27/2026 | 2.91 USD |
| 7/23/2026 | 2.93 USD |
| 7/22/2026 | 3.05 USD |
| 7/21/2026 | 3.08 USD |
| 7/20/2026 | 3.08 USD |
| 7/17/2026 | 3.11 USD |
| 7/16/2026 | 3.13 USD |
| 7/15/2026 | 3.05 USD |
| 7/14/2026 | 2.98 USD |
| 7/13/2026 | 2.95 USD |
| 7/10/2026 | 2.96 USD |
| 7/9/2026 | 3.09 USD |
| 7/8/2026 | 3.08 USD |
| 7/7/2026 | 3.03 USD |
| 7/6/2026 | 3.21 USD |
| 7/2/2026 | 3.06 USD |
| 7/1/2026 | 3.09 USD |
| 6/30/2026 | 3.19 USD |
| 6/29/2026 | 3.21 USD |
| 6/26/2026 | 3.06 USD |
| 6/25/2026 | 3.03 USD |
| 6/24/2026 | 3.14 USD |
| 6/23/2026 | 3.05 USD |
| 6/22/2026 | 3.19 USD |
| 6/18/2026 | 2.90 USD |
| 6/17/2026 | 3.06 USD |
| 6/16/2026 | 3.31 USD |
| 6/15/2026 | 3.41 USD |
| 6/12/2026 | 3.39 USD |
| 6/11/2026 | 3.52 USD |
| 6/10/2026 | 3.41 USD |
| 6/9/2026 | 3.53 USD |
| 6/8/2026 | 3.53 USD |
| 6/5/2026 | 3.58 USD |
| 6/4/2026 | 3.58 USD |
| 6/3/2026 | 3.51 USD |
| 6/2/2026 | 3.55 USD |
| 6/1/2026 | 3.55 USD |
| 5/29/2026 | 3.49 USD |
| 5/28/2026 | 3.64 USD |
| 5/27/2026 | 3.40 USD |
| 5/26/2026 | 3.48 USD |
| 5/22/2026 | 3.64 USD |
| 5/21/2026 | 3.49 USD |
| 5/20/2026 | 3.53 USD |
| 5/19/2026 | 3.45 USD |
| 5/18/2026 | 3.42 USD |
| 5/15/2026 | 3.60 USD |
| 5/14/2026 | 3.59 USD |
| 5/13/2026 | 3.50 USD |
| 5/12/2026 | 3.65 USD |
| 5/11/2026 | 3.65 USD |
| 5/8/2026 | 3.75 USD |
| 5/7/2026 | 3.79 USD |
| 5/6/2026 | 3.97 USD |
| 5/5/2026 | 4.08 USD |
| 5/4/2026 | 3.70 USD |
| 5/1/2026 | 3.86 USD |
| 4/30/2026 | 3.87 USD |
| 4/29/2026 | 3.79 USD |
| 4/28/2026 | 3.76 USD |
| 4/27/2026 | 3.89 USD |
| 4/24/2026 | 4.00 USD |
| 4/23/2026 | 4.09 USD |
| 4/22/2026 | 4.17 USD |
| 4/21/2026 | 4.18 USD |
| 4/20/2026 | 4.20 USD |
| 4/17/2026 | 4.30 USD |
| 4/16/2026 | 4.09 USD |
| 4/15/2026 | 4.08 USD |
| 4/14/2026 | 4.06 USD |
| 4/13/2026 | 3.98 USD |
| 4/10/2026 | 3.90 USD |
| 4/9/2026 | 3.85 USD |
| 4/8/2026 | 3.92 USD |
| 4/7/2026 | 4.00 USD |
| 4/6/2026 | 3.73 USD |
| 4/2/2026 | 3.63 USD |
| 4/1/2026 | 3.60 USD |
| 3/31/2026 | 3.53 USD |
| 3/30/2026 | 3.46 USD |
| 3/27/2026 | 3.86 USD |
| 3/26/2026 | 3.85 USD |
| 3/25/2026 | 3.80 USD |
| 3/24/2026 | 3.75 USD |
| 3/23/2026 | 3.84 USD |
| 3/20/2026 | 3.69 USD |
| 3/19/2026 | 3.95 USD |
| 3/18/2026 | 3.93 USD |
| 3/17/2026 | 3.91 USD |
| 3/16/2026 | 3.80 USD |
| 3/13/2026 | 3.73 USD |
| 3/12/2026 | 3.81 USD |
| 3/11/2026 | 3.94 USD |
| 3/10/2026 | 4.02 USD |
| 3/9/2026 | 4.25 USD |
| 3/6/2026 | 4.36 USD |
| 3/5/2026 | 4.24 USD |
| 3/4/2026 | 4.20 USD |
| 3/3/2026 | 4.14 USD |
| 3/2/2026 | 4.31 USD |
| 2/27/2026 | 4.44 USD |
| 2/26/2026 | 4.31 USD |
| 2/25/2026 | 4.46 USD |
| 2/24/2026 | 4.43 USD |
| 2/23/2026 | 4.34 USD |
| 2/20/2026 | 4.43 USD |
| 2/19/2026 | 4.20 USD |
| 2/18/2026 | 4.00 USD |
| 2/17/2026 | 4.28 USD |
| 2/13/2026 | 4.11 USD |
| 2/12/2026 | 4.06 USD |
| 2/11/2026 | 4.31 USD |
| 2/10/2026 | 4.36 USD |
| 2/9/2026 | 4.26 USD |
| 2/6/2026 | 4.35 USD |
| 2/5/2026 | 4.35 USD |
| 2/4/2026 | 4.32 USD |
| 2/3/2026 | 4.56 USD |
| 2/2/2026 | 4.69 USD |
| 1/30/2026 | 4.79 USD |
| 1/29/2026 | 4.52 USD |
| 1/28/2026 | 4.70 USD |
| 1/27/2026 | 4.97 USD |
| 1/26/2026 | 4.81 USD |
| 1/23/2026 | 4.80 USD |
| 1/22/2026 | 4.52 USD |
| 1/21/2026 | 4.45 USD |
| 1/20/2026 | 4.60 USD |
| 1/16/2026 | 4.36 USD |
| 1/15/2026 | 4.37 USD |
| 1/14/2026 | 4.25 USD |
| 1/13/2026 | 4.24 USD |
| 1/12/2026 | 4.22 USD |
| 1/9/2026 | 4.37 USD |
| 1/8/2026 | 4.42 USD |
| 1/7/2026 | 4.53 USD |
| 1/6/2026 | 4.41 USD |
| 1/5/2026 | 4.48 USD |
| 1/2/2026 | 4.43 USD |
| 12/31/2025 | 4.54 USD |
| 12/30/2025 | 4.68 USD |
| 12/29/2025 | 5.57 USD |
| 12/26/2025 | 4.80 USD |
| 12/24/2025 | 4.74 USD |
| 12/23/2025 | 4.53 USD |
| 12/22/2025 | 4.38 USD |
| 12/19/2025 | 4.49 USD |
| 12/18/2025 | 4.53 USD |
| 12/17/2025 | 4.40 USD |
| 12/16/2025 | 4.49 USD |
| 12/15/2025 | 4.84 USD |
| 12/12/2025 | 5.10 USD |
| 12/11/2025 | 4.97 USD |
| 12/10/2025 | 4.89 USD |
| 12/9/2025 | 4.93 USD |
| 12/8/2025 | 4.94 USD |
| 12/5/2025 | 4.82 USD |
| 12/4/2025 | 5.06 USD |
| 12/3/2025 | 4.56 USD |
| 12/2/2025 | 4.62 USD |
| 12/1/2025 | 4.94 USD |
| 11/28/2025 | 4.95 USD |
| 11/26/2025 | 4.85 USD |
| 11/25/2025 | 4.79 USD |
| 11/24/2025 | 4.68 USD |
| 11/21/2025 | 4.78 USD |
| 11/20/2025 | 5.04 USD |
| 11/19/2025 | 5.15 USD |
| 11/18/2025 | 5.11 USD |
| 11/17/2025 | 5.38 USD |
| 11/14/2025 | 5.50 USD |
| 11/13/2025 | 5.64 USD |
| 11/12/2025 | 5.86 USD |
| 11/11/2025 | 6.09 USD |
| 11/10/2025 | 5.97 USD |
| 11/7/2025 | 6.03 USD |
| 11/6/2025 | 5.53 USD |
| 11/5/2025 | 5.95 USD |
| 11/4/2025 | 5.78 USD |
| 11/3/2025 | 6.22 USD |
| 10/31/2025 | 6.73 USD |
| 10/30/2025 | 6.91 USD |
| 10/29/2025 | 6.93 USD |
| 10/28/2025 | 7.76 USD |
| 10/27/2025 | 7.03 USD |
| 10/24/2025 | 7.15 USD |
| 10/23/2025 | 7.00 USD |
| 10/22/2025 | 7.04 USD |
| 10/21/2025 | 7.28 USD |
| 10/20/2025 | 7.25 USD |
| 10/17/2025 | 7.48 USD |
| 10/16/2025 | 7.70 USD |
| 10/15/2025 | 7.53 USD |
| 10/14/2025 | 7.63 USD |
| 10/13/2025 | 7.34 USD |
| 10/10/2025 | 7.51 USD |
| 10/9/2025 | 7.91 USD |
| 10/8/2025 | 8.50 USD |
| 10/7/2025 | 7.84 USD |
| 10/6/2025 | 7.84 USD |
| 10/3/2025 | 7.43 USD |
| 10/2/2025 | 7.34 USD |
| 10/1/2025 | 7.27 USD |
| 9/30/2025 | 7.05 USD |
| 9/29/2025 | 7.06 USD |
| 9/26/2025 | 7.26 USD |
| 9/25/2025 | 7.17 USD |
| 9/24/2025 | 7.27 USD |
| 9/23/2025 | 7.04 USD |
| 9/22/2025 | 7.29 USD |
| 9/19/2025 | 7.22 USD |
| 9/18/2025 | 7.26 USD |
| 9/17/2025 | 6.92 USD |
| 9/16/2025 | 7.15 USD |
| 9/15/2025 | 6.74 USD |
| 9/12/2025 | 7.15 USD |
| 9/11/2025 | 6.93 USD |
| 9/10/2025 | 6.00 USD |
| 9/9/2025 | 6.08 USD |
| 9/8/2025 | 6.26 USD |
| 9/5/2025 | 6.38 USD |
| 9/4/2025 | 6.23 USD |
| 9/3/2025 | 6.35 USD |
| 9/2/2025 | 6.17 USD |
| 8/29/2025 | 6.47 USD |
| 8/28/2025 | 6.53 USD |
| 8/27/2025 | 6.41 USD |
| 8/26/2025 | 6.45 USD |
| 8/25/2025 | 6.41 USD |
| 8/22/2025 | 6.43 USD |
| 8/21/2025 | 6.31 USD |
| 8/20/2025 | 6.22 USD |
| 8/19/2025 | 6.22 USD |
| 8/18/2025 | 6.36 USD |
| 8/15/2025 | 6.57 USD |
| 8/14/2025 | 6.30 USD |
| 8/13/2025 | 6.66 USD |
| 8/12/2025 | 6.80 USD |
Nutriband Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Nutriband Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027e |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | – |
| – | – | – | – | – | – | – | 100.00 | – | – | – | – |
| – | – | – | -3.00 | -2.00 | -2.00 | -6.00 | -4.00 | -5.00 | -6.00 | -8.00 | – |
| – | – | – | – | – | – | -600.00 | -200.00 | -250.00 | -300.00 | -400.00 | – |
| – | – | -2.00 | -3.00 | -2.00 | -3.00 | -8.00 | -4.00 | -5.00 | -10.00 | -8.00 | – |
| – | – | – | 50.00 | -33.33 | 50.00 | 166.67 | -50.00 | 25.00 | 100.00 | -20.00 | – |
| 6.06 | 6.06 | 6.37 | 6.33 | 6.44 | 7.59 | 7.80 | 7.83 | 11.10 | 12.06 | 12.16 | 12.16 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Nutriband generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Nutriband retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Nutriband's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Nutriband has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Nutriband's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Nutriband stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Nutriband Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Nutriband business model & stock analysis
Nutriband SWOT Analysis
Strengths
[ { "heading": "1.", "text": "Innovative" } ]
Nutriband Inc has developed a range of innovative and high-quality products that address various health and wellness needs. This unique product line gives the company a competitive advantage in the market.
[ { "heading": "2.", "text": "Strong" } ]
Nutriband Inc has established a strong presence in the market, with a loyal customer base and a recognized brand. This market presence provides the company with opportunities for expansion and growth.
[ { "heading": "3.", "text": "Strategic" } ]
The company has formed strategic partnerships with key suppliers, distributors, and retailers. These partnerships enable Nutriband Inc to reach a wider customer base and enhance its distribution channels.
Weaknesses
[ { "heading": "1.", "text": "Limited" } ]
Nutriband Inc currently holds a relatively small market share compared to its competitors. This limitation may hinder its ability to compete effectively in the industry.
[ { "heading": "2.", "text": "Dependence" } ]
The company relies heavily on third-party manufacturers for its product production. This dependency may lead to quality control issues or disruptions in the supply chain.
[ { "heading": "3.", "text": "Limited" } ]
Nutriband Inc has limited financial resources compared to larger competitors. This financial constraint may restrict the company's ability to invest in research and development or marketing initiatives.
Opportunities
[ { "heading": "1.", "text": "Growing" } ]
The increasing demand for health and wellness products presents a significant opportunity for Nutriband Inc to expand its customer base and increase sales.
[ { "heading": "2.", "text": "Expansion" } ]
Nutriband Inc can explore potential expansion into new international markets, leveraging its innovative product line and established brand to capture market share globally.
[ { "heading": "3.", "text": "Diversification" } ]
The company can consider diversifying its product portfolio by introducing new products or exploring partnerships/acquisitions to cater to emerging trends and consumer preferences in the health and wellness industry.
Threats
[ { "heading": "1.", "text": "Intense" } ]
The market for health and wellness products is highly competitive, with numerous established players and new entrants. Nutriband Inc faces the risk of losing market share to competitors who offer similar or alternative products.
[ { "heading": "2.", "text": "Stringent" } ]
The health and wellness industry is subject to strict regulations and compliance standards. Non-compliance or changes in regulations can pose challenges for Nutriband Inc, including increased costs or product recalls.
[ { "heading": "3.", "text": "Economic" } ]
Economic volatility or recessions can impact consumer spending on health and wellness products. Nutriband Inc may face decreased demand during challenging economic conditions, affecting its revenue and profitability.
Nutriband Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Nutriband Segments
Nutriband Revenue by Region
3 Years
5 Years
Max
Details
Nutriband Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Nutriband historical P/E ratio, EBIT multiple, and P/S ratio
Nutriband annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Nutriband shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Nutriband stock splits
Current Nutriband forecasts and price targets in August 2026
Analyst Price Targets 2026Nutriband Analyst Rating Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| 7/26/2022 | Maintained | Buy |
Nutriband Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 4/27/2026 | -1.93USD | - | 780,300.00USD | - | 2026 Q4 |
| 12/2/2025 | -2.17USD | - | 688,500.00USD | - | 2026 Q3 |
| 4/27/2023 | -0.04USD | - | 725,217.00USD | - | 2023 Q4 |
| 12/12/2022 | -0.06USD | - | 571,445.00USD | - | 2023 Q3 |
| 9/8/2022 | -0.07USD | - | 541,502.00USD | - | 2023 Q2 |
| 5/31/2022 | -0.06USD | - | 507,499.00USD | - | 2023 Q1 |
| 4/29/2022 | -0.09USD | - | 329,874.00USD | - | 2022 Q4 |
| 12/14/2021 | -0.04USD | - | 508,514.00USD | - | 2022 Q3 |
| 9/3/2021 | 0.01USD | - | 720,649.00USD | - | 2022 Q2 |
| 6/14/2021 | -USD | - | 512,574.00USD | - | 2022 Q1 |
Nutriband shareholder structure
| % | Name |
|---|---|
25.36789% | |
14.47549% | |
6.77896% | |
6.74131% | |
1.64032% | |
0.70941% |
Nutriband Executives and Management Board
9 members · avg. age 52 · 11 % women
Mr. Serguei Melnik (51)
Chairman of the Board, President, Interim Chief Executive Officer, Secretary · since 2016
358,368.00 USD
Management
Dr. Jeff Patrick (55)
Chief Scientific Officer
Dr. Alan Smith (57)
Chief Operating Officer, President of 4P Therapeutics
Mr. Gerald Goodman (76)
Chief Financial Officer
Board of Directors
Mr. Mark Hamilton (37)
Independent Director
Mr. Radu Bujoreanu (54)
Independent Director
Prof. Dr. Stefani Mancas (47)
Independent Director
Ms. Irina Gram (36)
Independent Director
Mr. Sergei Glinka (59)
Independent Director
Frequently asked questions about Nutriband
The business model of Nutriband Inc revolves around developing and marketing innovative transdermal patches that deliver essential nutrients, vitamins, and other beneficial substances to the body. Nutriband specializes in creating patches that offer an alternative delivery system for various health and wellness products. By leveraging advanced technology and research, Nutriband aims to provide consumers with convenient and effective solutions to address their nutritional needs. The company focuses on creating partnerships with manufacturers, distributors, and retailers to scale its business globally. Nutriband Inc continuously strives to enhance its product formulations and expand its range to cater to a wide range of health-conscious individuals.
Nutriband Inc is primarily active in the health and wellness industry.
The main competitors of Nutriband Inc in the market are companies like Herbalife Nutrition Ltd, Pfizer Inc, GlaxoSmithKline PLC, and Johnson & Johnson.
Nutriband Inc is a global company specializing in the development and commercialization of advanced transdermal drug delivery systems. Founded in 2010, Nutriband has established itself as a leader in the industry through its innovative and effective medical patch technology. The company focuses on developing products that enhance patient care and convenience, offering pharmaceutical, over-the-counter, and cannabis-infused patches. Nutriband Inc has successfully launched a range of products and is committed to continued research and development to provide cutting-edge solutions in the healthcare sector. With its expertise and dedication, Nutriband Inc has become a trusted name in the field of transdermal drug delivery.
Nutriband Inc has achieved several significant milestones. The company successfully launched its flagship product line, utilizing innovative transdermal patch technology for efficient nutrient delivery. Nutriband Inc also expanded its distribution channels, securing partnerships with major retailers and expanding its global market reach. Additionally, the company attained regulatory approvals for its products, ensuring compliance and safety. Nutriband Inc has demonstrated consistent growth, driven by its dedication to research and development, customer satisfaction, and commitment to delivering high-quality, effective nutritional solutions. These milestones reflect Nutriband Inc's ongoing success and position in the market as a trusted provider of innovative and effective health products.
Nutriband Inc is primarily present in multiple countries and regions across the globe. The company has a global presence, including but not limited to the United States, Europe, Asia, and South America. With its headquarters located in Orlando, Florida, Nutriband Inc has successfully expanded its operations and market reach to cater to a diverse customer base. As a reputable player in the industry, Nutriband Inc continues to grow its international presence through strategic partnerships and distribution networks, ensuring its products and innovations are accessible to consumers worldwide.
Nutriband Inc represents a strong commitment to promoting health and wellness through its innovative products. With a focus on providing effective and convenient solutions, Nutriband Inc offers a range of transdermal patches that deliver essential nutrients and supplements. The company's philosophy centers around the belief that everyone deserves access to high-quality and science-backed wellness solutions. By combining cutting-edge technology with a dedication to research and development, Nutriband Inc strives to help individuals achieve optimal health and well-being. With a growing presence in the market, Nutriband Inc continues to prioritize customer satisfaction and transparency, ensuring the highest level of integrity in all its operations.
Analysts currently set an average price target of 15.30 USD for the Nutriband stock (median: 15.30 USD), implying +387.3 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Nutriband stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Nutriband share trades at 2.72 EUR (3.14 USD).
The Nutriband share (NTRB) is listed on 2 stock exchanges, including: NASDAQ (NTRB), Frankfurt (9WV.F).
Nutriband Inc is an American company that specializes in the manufacturing and distribution of transdermal patch products. The company is headquartered in Orlando, Florida, and was founded in 2010. Nutriband's business model is based on innovative transdermal patch technologies that allow customers to absorb nutrients, medications, and other active ingredients directly through the skin. The products are easy to use and offer a variety of advantages over traditional oral medications. Nutriband has a wide range of products tailored to different customer needs, including supplements, pain therapy, medication delivery, and wellness. The company has a strong distribution channel that enables global sales, including partnerships with various distributors and online platforms like Amazon. Overall, Nutriband has a robust business model based on innovative transdermal patch products and works with strong distribution partners to support product sales.
The revenue of Nutriband is 2.04 M USD. This figure is based on current financial data and reflects the company's business performance.
The profit of Nutriband is -8.23 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Nutriband is currently -4.64. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Nutriband stock.
The price-to-sales ratio (P/S) of Nutriband is currently 18.74. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Nutriband stock.
The Eulerpool Quality Score for Nutriband is 3/10.
The ISIN of Nutriband is US67092M2089. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Nutriband is A3C484. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Nutriband is NTRB. The ticker symbol is used to trade Nutriband shares on the stock exchange.
Nutriband paid dividends every year for the past 0 years.
Nutriband is assigned to the 'Non-cyclical consumption' sector.
The dividends of Nutriband are distributed in USD.
Nutriband stock
Nutriband Peer Group
Nutriband Ticker
Nutriband FIGI
All fundamentals and in-depth analysis of Nutriband
Our stock analysis for Nutriband stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nutriband. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.